Selegiline (Eldepryl, Emsam) — Research Compounds Library | RetatrutideCompare

Selective irreversible MAO-B inhibitor at low doses; loses selectivity at high doses. FDA-approved for Parkinson's disease (oral) and major depression (transdermal patch).